BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 11716039)

  • 1. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy.
    Jyonouchi SC; Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
    Thyroid; 2001 Oct; 11(10):929-34. PubMed ID: 11716039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy.
    Bahn RS; Dutton CM; Natt N; Joba W; Spitzweg C; Heufelder AE
    J Clin Endocrinol Metab; 1998 Mar; 83(3):998-1002. PubMed ID: 9506762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin.
    Bahn RS; Dutton CM; Joba W; Heufelder AE
    Thyroid; 1998 Feb; 8(2):193-6. PubMed ID: 9510130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.
    Bahn RS
    Thyroid; 2002 Mar; 12(3):193-5. PubMed ID: 11952038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.
    Kumar S; Schiefer R; Coenen MJ; Bahn RS
    Thyroid; 2010 Jan; 20(1):59-65. PubMed ID: 20017620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts.
    Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
    J Clin Endocrinol Metab; 2002 May; 87(5):2352-8. PubMed ID: 11994387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor.
    Valyasevi RW; Erickson DZ; Harteneck DA; Dutton CM; Heufelder AE; Jyonouchi SC; Bahn RS
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2557-62. PubMed ID: 10404836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2011 Feb; 21(2):169-76. PubMed ID: 20954819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
    Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
    Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tumor necrosis factor-alpha, interferon-gamma, and transforming growth factor-beta on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts.
    Valyasevi RW; Jyonouchi SC; Dutton CM; Munsakul N; Bahn RS
    J Clin Endocrinol Metab; 2001 Feb; 86(2):903-8. PubMed ID: 11158064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
    van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy.
    Bahn RS
    J Endocrinol Invest; 2004 Mar; 27(3):216-20. PubMed ID: 15164996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.
    Smith TJ; Padovani-Claudio DA; Lu Y; Raychaudhuri N; Fernando R; Atkins S; Gillespie EF; Gianoukakis AG; Miller BS; Gauger PG; Doherty GM; Douglas RS
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3827-37. PubMed ID: 21956421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy.
    Pasquali D; Pierantoni GM; Fusco A; Staibano S; Colantuoni V; De Bellis A; Bellastella A; Sinisi AA
    J Mol Endocrinol; 2004 Aug; 33(1):133-43. PubMed ID: 15291748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of leptin expression in orbital preadipocyte fibroblasts.
    Erickson DZ; Harteneck DA; Erickson BJ; Dutton CM; Bahn RS
    Thyroid; 2001 Mar; 11(3):221-6. PubMed ID: 11327612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation.
    Agretti P; De Marco G; De Servi M; Marcocci C; Vitti P; Pinchera A; Tonacchera M
    Eur J Endocrinol; 2005 May; 152(5):777-84. PubMed ID: 15879364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
    Dik WA; Virakul S; van Steensel L
    Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy.
    Kumar S; Coenen MJ; Scherer PE; Bahn RS
    J Clin Endocrinol Metab; 2004 Feb; 89(2):930-5. PubMed ID: 14764816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A drug-like antagonist inhibits thyrotropin receptor-mediated stimulation of cAMP production in Graves' orbital fibroblasts.
    Neumann S; Pope A; Geras-Raaka E; Raaka BM; Bahn RS; Gershengorn MC
    Thyroid; 2012 Aug; 22(8):839-43. PubMed ID: 22784331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.